|
Market Closed -
Nasdaq
16:00:00 2026-08-17 EDT
|
5-day change | 1st Jan Change | ||
| 21.47 USD | -0.14% |
|
+3.82% | +123.41% |
| 07-30 | B. Riley Adjusts Anika Therapeutics Price Target to $21 From $18, Maintains Buy Rating | MT |
| 07-30 | Barrington Raises Price Target on Anika Therapeutics to $21 From $17, Keeps Outperform Rating | MT |
| Market Cap | 287M 248M 233M 212M 399M 27.47B 404M 2.73B 1.07B 13.76B 1.08B 1.06B 45.78B | P/E 2026 * |
-2,147x | P/E 2027 * | 46.2x |
|---|---|---|---|---|---|
| Enterprise Value | 287M 248M 233M 212M 399M 27.47B 404M 2.73B 1.07B 13.76B 1.08B 1.06B 45.78B | EV / Sales 2026 * |
2.35x | EV / Sales 2027 * | 2.24x |
| Free-Float |
79.73% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Anika Therapeutics, Inc.
| 1 day | -0.14% | ||
| 1 week | +3.82% | ||
| Current month | +11.36% | ||
| 1 month | +40.79% | ||
| 3 months | +44.00% | ||
| 6 months | +106.05% | ||
| Current year | +123.41% |
| 1 week | 20.42 |  | 22.42 |
| 1 month | 14.58 | | 22.88 |
| Current year | 9.01 | | 22.88 |
| 1 year | 8.22 | | 22.88 |
| 3 years | 7.87 | | 29.12 |
| 5 years | 7.87 | | 45.81 |
| 10 years | 7.87 | | 75.72 |
| Manager | Title | Age | Since |
|---|---|---|---|
Stephen Griffin
CEO | Chief Executive Officer | 40 | 2026-01-31 |
Mira Leiwant
CTO | Chief Tech/Sci/R&D Officer | - | 2019-10-13 |
Dawn J. Wilson
CTO | Chief Tech/Sci/R&D Officer | - | 2023-08-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Cheryl Blanchard
CHM | Chairman | 61 | 2026-01-31 |
John Henneman
CHM | Chairman | 64 | 2024-02-23 |
Stephen Richard
BRD | Director/Board Member | 63 | 2020-09-02 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 8/4/26 | Buy | Director | 1,000 | 0.0075% | ||
| 2/1/26 | Other | Chief Executive Officer | 440,609 | 3.0553% | ||
| 6/20/25 | Free | Director | 14,164 | 0.0967% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.14% | +3.82% | +143.15% | +16.18% | 287M | |
| -0.79% | +1.61% | -16.23% | +5.18% | 191B | |
| -0.73% | +1.33% | -2.60% | +11.08% | 116B | |
| -0.41% | -3.84% | +6.73% | +73.62% | 59.64B | |
| -0.42% | +1.08% | +34.00% | +70.00% | 55.42B | |
| -0.71% | +1.37% | -7.07% | -33.92% | 49.6B | |
| -1.10% | +1.27% | +9.65% | -17.67% | 33.49B | |
| -2.41% | +3.16% | - | - | 30.6B | |
| -1.60% | -0.79% | -7.55% | +24.99% | 24.25B | |
| -0.80% | -1.57% | +40.78% | -11.77% | 24.39B | |
| Average | -0.91% | +0.94% | +22.32% | +15.30% | 58.46B | |
| Weighted average by Cap. | -0.83% | +0.81% | -0.52% | +15.51% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 122M 106M 99M 90.17M 170M 11.69B 172M 1.16B 455M 5.86B 459M 449M 19.48B | 129M 111M 104M 94.84M 178M 12.29B 181M 1.22B 478M 6.16B 483M 472M 20.49B |
| Net income | -67.5K -58.27K -54.67K -49.79K -93.63K -6.45M -94.93K -641K -251K -3.23M -253K -248K -10.76M | 6.42M 5.55M 5.2M 4.74M 8.91M 614M 9.03M 60.99M 23.9M 308M 24.12M 23.59M 1.02B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-17 | US$21.47 | -0.14% | 121,228 |
| 26-08-14 | US$21.50 | +1.56% | 124,986 |
| 26-08-13 | US$21.17 | -3.90% | 102,066 |
| 26-08-12 | US$22.03 | +3.77% | 141,049 |
| 26-08-11 | US$21.23 | +2.66% | 114,214 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ANIK Stock
Select your edition
All financial news and data tailored to specific country editions
